Sbi Securities Co., Ltd. Clearside Biomedical, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 782 shares of CLSD stock, worth $3,034. This represents 0.0% of its overall portfolio holdings.
Number of Shares
782
Previous 485
61.24%
Holding current value
$3,034
Previous $445,000
40.67%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CLSD
# of Institutions
45Shares Held
11.6MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA3.36MShares$13 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$8.53 Million3.43% of portfolio
-
Carmignac Gestion Paris, I01.51MShares$5.85 Million0.02% of portfolio
-
Black Rock Inc. New York, NY798KShares$3.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA790KShares$3.07 Million0.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $234M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...